Return of Bowel Function After One or Two Level Anterior Lumbar Interbody Fusion With Chewing Gum

February 27, 2023 updated by: Maziyar A. Kalani, Mayo Clinic
Researchers are trying to identify is chewing gum improves bowel function after anterior lumbar interbody fusion

Study Overview

Detailed Description

Aims, purpose, or objectives:

  1. Observe changes in bowel pattern based on gum-chewing
  2. Examine bowel function after anterior lumbar interbody fusion
  3. Measure length of time to return of bowel function after anterior lumbar interbody fusion
  4. Compare return of bowel function in patients who chew gum and patients standardized to usual post-operative care
  5. Measure the hospital length of stay amongst study groups
  6. Measure post-operative pain amongst study groups

Background (Include relevant experience, gaps in current knowledge, preliminary data, etc.):

One or two level anterior lumbar interbody fusions are designed to correct lumbar spondylosis and spondylolisthesis, which can cause debilitating back and leg pain. This surgery involves an anterior approach, which often requires displacement of bowel for the length of the surgery. Patients frequently have a slow return of bowel function secondary to anesthetic time, opioid use, and primarily due to the bowel displacement intraoperatively. Because this is a one or two level surgery, many patients would benefit from same-day discharge but often remain inpatient several days due to slow return of bowel function.

Gum chewing has been shown to decrease the time for return to bowel function (RBF) in colorectal and gynecology patients postoperatively.

Gum chewing and RBF has been studied in the spine population for posterior operations but not anterior spine surgery. This study aims to identify whether chewing gum has an impact on patient's report of pain, RBF, length of stay, and subjective report of satisfaction post-operatively. This could be an outpatient operation; however, pain and RBF often prevent patients from discharging home the same day of surgery.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Undergoing one or two level anterior lumbar interbody fusion
  2. Diagnosis of spondylosis, spondylolisthesis, revision of foraminal stenosis or neurogenic claudication

Exclusion Criteria:

  1. Previous bowel surgery
  2. Diagnosis of an inflammatory bowel disease
  3. Allergy to xylitol
  4. Pregnancy

Some participants may subsequently undergo a posterior spinal fusion on the same-day of surgery. They will not be excluded, but the investigators will include this group in a different data subset.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Gum chewing
Chew xylitol based, peppermint flavored gum for 30 minutes every two hours during the hours of 7 am to 9 pm, for the first 24 hours after your surgery
xylitol based, peppermint flavored gum
No Intervention: Standard Care
Standard hospital management with no deviations from usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in bowel pattern based on gum-chewing
Time Frame: 24 hours after surgery
Number of hours until return of bowel sounds
24 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bowel function
Time Frame: Number of hours from admission to discharge up to 48 hours
Number of hours until return of flatus
Number of hours from admission to discharge up to 48 hours
Length of time to return of bowel function after anterior lumbar interbody fusion
Time Frame: Number of hours from admission to discharge up to 48 hours
Number of hours until complete bowel movement
Number of hours from admission to discharge up to 48 hours
Total length of hospital
Time Frame: Number of hours from admission to discharge up to 48 hours
Number of hours of hospital stay
Number of hours from admission to discharge up to 48 hours
Pain score
Time Frame: 24 hours post-operatively
On a scale of 0 (zero pain) and 10 (worst pain)
24 hours post-operatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Maziyar Kalani, MD, Mayo Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2019

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

April 4, 2019

First Submitted That Met QC Criteria

May 9, 2019

First Posted (Actual)

May 10, 2019

Study Record Updates

Last Update Posted (Estimate)

February 28, 2023

Last Update Submitted That Met QC Criteria

February 27, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 18-011849

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spondylosis

Clinical Trials on Chewing gum

3
Subscribe